Media
A Fit-for-Purpose Synthesis of a Chiral Oxa-azaspiro Building Block
Press Release
Aragen Launches CHOMax™, an Accelerated Platform for DNA to IND-Enabling Clinical Supply in ~10 Months
Media
Aragen Life Sciences: Trusted R&D and Manufacturing Partner
Media
Aragen shares 2026 predictions
Press Release
Incidence of Spontaneous and Urethane-Induced Tumors in a 26-Week Carcinogenicity Study in Tg.rasH2 Mice Sourced From CLEA, Japan
Media
Mechanistic insights into PROTAC-mediated degradation through an integrated framework of molecular dynamics, free energy landscapes, and quantum mechanics: A case study on kinase degraders
Media
A Fit-for-Purpose Synthesis of a Chiral Oxa-azaspiro Building Block
Press Release
Aragen Launches CHOMax™, an Accelerated Platform for DNA to IND-Enabling Clinical Supply in ~10 Months
Media
Aragen Life Sciences: Trusted R&D and Manufacturing Partner
Media
Aragen shares 2026 predictions
Press Release
Incidence of Spontaneous and Urethane-Induced Tumors in a 26-Week Carcinogenicity Study in Tg.rasH2 Mice Sourced From CLEA, Japan
Media
Mechanistic insights into PROTAC-mediated degradation through an integrated framework of molecular dynamics, free energy landscapes, and quantum mechanics: A case study on kinase degraders
April 13 - 16, 2026
San Diego, California, USA
April 17 - 22, 2026
Diego, California, USA
April 21 - 23, 2026
East Hall 2-2C26
Tokyo, Japan
April 28-30, 2026
Boston, MA, USA
May 11-15, 2026
Boston, MA, USA
May 14–15, 2026
Pune, Maharashtra, India
September 8-9, 2026
Stockholm, Sweden
September 6-10, 2026
Basel, Switzerland
April 13 - 16, 2026
San Diego, California, USA
April 17 - 22, 2026
Diego, California, USA
April 21 - 23, 2026
East Hall 2-2C26
Tokyo, Japan
April 28-30, 2026
Boston, MA, USA
May 11-15, 2026
Boston, MA, USA
May 14–15, 2026
Pune, Maharashtra, India
September 8-9, 2026
Stockholm, Sweden
September 6-10, 2026
Basel, Switzerland
Key brand assets for use across all communication.
Quick snapshot of our company, including relevant facts and numbers.
